HB0113

Adding convictions for resisting arrest, making a false statement to a law enforcement officer, and making a false statement to a law enforcement officer when under arrest to the list of misdemeanor convictions that a person may expunge under certain circumstances

HB0131

(SB0315)

Clarifying that refusal by a person to disclose information about criminal charges that have been expunged may not be the sole reason for a unit, an official, or an employee of the State or a political subdivision of the State to deny the person's application for a license, permit, registration, or governmental service; providing that refusal by a person to disclose information about criminal charges that have been expunged may not be the sole reason for an educational institution to expel or refuse to admit the person; etc.

Support

Testimony

HB0187

(SB0320)

Authorizing the expungement of a disposition under a certain provision of law if the disposition was included in a case that was disposed of by the court with a no finding designation or designated by the court as having been terminated without finding

Criminal Procedure - Expungement - Effect

Authorizing a person to file a petition for expungement of a conviction of failure to obey a court order to report to a place of confinement; and prohibiting a person from filing a petition for expungement of a conviction of failure to obey a court order to report to a place of confinement until 15 years after the completion of the sentence.

Monitor

HB0797 

(SB0439)

Prohibiting an employer from taking certain discriminatory employment actions against a fire and rescue public safety employee based on the employee's use of medical cannabis, subject to certain conditions; and requiring an employer to report an incident of a fire and rescue public safety employee reporting for work while impaired by cannabis to the State Emergency Medical Services Board.

Support

Testimony

HB0819

(SB0464)

Establishing the Commission to Examine the Expungement Laws of Maryland for issues of efficiency and equity; and requiring the Commission to submit a certain report to the General Assembly on or before December 31, 2027.

Support

Testimony

Altering a certain list of felony convictions that are eligible for expungement to include distributing or dispensing a controlled dangerous substance.

Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for services provided in any setting by certain certified peer recovery specialists; and requiring the Maryland Department of Health to convene a certain workgroup on the certification process of peer recovery specialists.

Support

Testimony

HB1014 

(SB0707)

Defining "danger to the life or safety of the individual or of others" for purposes of the involuntary admission of individuals with mental disorders to a facility or Veterans' Administration hospital and the emergency evaluation of individuals with mental disorders.

Requiring that the requirements for the certification of recovery residences established by a credentialing entity prohibit a certified recovery residence from refusing services to an individual receiving medication-assisted treatment for opioid use disorder or requiring an individual to cease receiving or modify how the individual receives medication-assisted treatment for opioid use disorder as a condition to receive services from a certified recovery residence

Monitor

HB1309

(SB0752)

Establishing the Commission to Review and Assess Racial Disparities in the State Criminal Justice System to study and make recommendations on certain matters involving the disparate treatment of African Americans, Hispanics, and other non-White individuals in the State's criminal justice system and other criminal justice issues in the State; and requiring the Commission to submit a final report of its findings and recommendations on or before September 1, 2028.

Support

Testimony

HB1386

SB0906

Prohibiting a certain individual from distributing heroin or fentanyl or chemical analogues of heroin or fentanyl, the use of which results in the death of or serious bodily injury to another; and providing that a person who violates the Act is guilty of a felony and, in addition to any other penalty imposed for a certain violation, on conviction is subject to imprisonment not exceeding 20 years.

Oppose

Testimony

HB1477

(SB0527)

Establishing the Ibogaine Clinical Research Grant Program to provide grants to certain research institutions to conduct certain clinical drug development trials on the use of ibogaine; and including the Program as an authorized use of funding from the Opioid Restitution Fund.

Support

Testimony

Requiring the Maryland Department of Health to establish by regulation standards relating to the discharge of patients from drug and alcohol treatment programs and certain referral services offered to patients by certain drug and alcohol treatment programs; and requiring the Department to submit a report on the status of the adoption and revision of regulations to implement the requirements of the Act and Chapter 580 of 2017, and a plan for the enforcement of the statutory and regulatory requirements under the Act and Chapter 580 of 2017.

Monitor

SB0244

(HB0529)

Passed Senate, now in the House Health Comm. - First Reading 

Cross-file (HB529) Passed by House.

Support

Testimony

SB0315

(HB0131)

Support

Testimony

SB0320

(HB0187)

Monitor

Extending through fiscal year 2030 the requirement that an appropriation of $500,000 be included in the annual budget bill for the Recovery Residence Grant Program.

Passed by Senate (41-0)

In House Appropriations Comm. - First Reading

Support

Testimony

SB0435 

(HB0417)

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.

Oppose

Testimony

SB0439 

(HB0797)

Prohibiting an employer from taking certain discriminatory employment actions against a fire and rescue public safety employee based on the employee's use of medical cannabis, subject to certain conditions; and requiring an employer to report an incident of a fire and rescue public safety employee reporting for work while impaired by cannabis to the State Emergency Medical Services Board.

Passed the Senate (33-11)

In House Economic Matters Comm. - First Reading

Support

Testimony

SB0464

(HB0819)

Establishing the Commission to Examine the Expungement Laws of Maryland; and requiring the Commission to submit a report of its findings and recommendations to the General Assembly on or before December 31, 2027.

Support

Testimony

SB0483 

(HB0360)

Requiring the Department of Public Safety and Correctional Services and the Judiciary to expunge all cases meeting certain criteria on or before July 1, 2028; and requiring the Department and the Judiciary to expunge certain newly eligible cases on a monthly basis.

Support

Testimony

SB0525 

(HB0169)

Authorizing a person to file a petition for expungement of any misdemeanor or felony conviction a certain period of time after the completion of the sentence, parole, probation, and any other form of mandatory treatment associated with the conviction; authorizing a court to grant a petition on a showing of good cause; and providing that a denial of a petition may not be appealed and a subsequent petition may not be filed for a certain period of time.

Support

Testimony

SB0527 

(HB1477)

Establishing the Ibogaine Clinical Research Grant Program to provide grants to certain research institutions to conduct certain clinical drug development trials on the use of ibogaine; and including the Program as an authorized use of funding from the Opioid Restitution Fund.

Support

Testimony

SB0707 

(HB1014)

Defining "danger to the life or safety of the individual or of others" for purposes of the involuntary admission of individuals with mental disorders to a facility or Veterans' Administration hospital and the emergency evaluation of individuals with mental disorders

SB0752 

(HB1309)

Establishing the Commission to Review and Assess Racial Disparities in the State Criminal Justice System to study and make recommendations on certain matters involving the disparate treatment of African Americans, Hispanics, and other non-White individuals in the State's criminal justice system and other criminal justice issues in the State; and requiring the Commission to submit a final report of its findings and recommendations on or before September 1, 2028.

Support

Testimony

SB0876

Requiring, beginning January 1, 2027, rather than authorizing, a recovery residence to be certified by a credentialing entity before operating in the State.

Support

Testimony

SB0878

(HB0448)

Requiring the Maryland Department of Health to conduct at least two on-site unannounced inspections of each certified recovery residence annually; authorizing the Department to direct the recovery residence credentialing entity to revoke the certification of a certified recovery residence that fails to correct a deficiency with 1 month after notice of the deficiency is provided; etc.

Support

Testimony

SB0906

Prohibiting a certain individual from distributing heroin or fentanyl or chemical analogues of heroin or fentanyl, the use of which results in the death of or serious bodily injury to another; and providing that a person who violates the Act is guilty of a felony and, in addition to any other penalty imposed for a certain violation, on conviction is subject to imprisonment not exceeding 20 years.

Oppose

Testimony